Stay updated on Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The Record History page shows a new UI revision tag, updating from Revision: v3.6.2 to Revision: v3.6.3. This is a system/format update to the page layout or framework and does not modify trial data, eligibility, or study results.
    Difference
    0.1%
    Check dated 2026-07-03T14:00:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The record history page shows a newer revision label (v3.6.2) compared to the previous version (v3.6.0), indicating an update to the page template used to display version history.
    Difference
    0.1%
    Check dated 2026-06-26T11:10:36.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Displays that recruitment is closed for the trial, and updates the study history with a new revision tag (v3.6.0) while removing the older v3.5.5 tag.
    Difference
    0.4%
    Check dated 2026-06-11T23:19:39.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.5' was added to the history. The previous 'Revision: v3.5.4' entry was removed, reflecting an update to the page's record history.
    Difference
    0.1%
    Check dated 2026-06-05T00:12:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is displayed instead of v3.5.3 on the page, indicating a minor system update to the Study History page.
    Difference
    0.1%
    Check dated 2026-05-21T13:46:17.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Pfizer terminated the MagnetisMM-4 umbrella study and will not pursue the Phase 2 expansion, changing its status to Terminated; the termination note specifies it was not due to safety concerns or regulatory requests.
    Difference
    0.5%
    Check dated 2026-04-30T03:25:03.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo Therapy in Multiple Myeloma Clinical Trial page.